If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
155.80    5.60 (3.73%)
Bid:
155.60
Ask:
156.00
Spread: 0.40 (0.257%)
Market Cap: £888.51m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Directorate Change

29 Jul 2021 07:00

RNS Number : 8257G
Elementis PLC
29 July 2021
 

 

Appointment of Chairman and Senior Independent Director

Elementis plc (ELM.L) (the "Company"), global specialty chemicals company, today announces the appointment of John O'Higgins as Non-Executive Chairman of the Company, effective from 1 September 2021. This follows the announcement in March 2021 that Andrew Duff, Chairman, would be stepping down from the Board this year, and a thorough, externally facilitated, recruitment process.

John will also chair the Nomination Committee. John was appointed as a Non-Executive Director on 4 February 2020 and became Senior Independent Director on 29 April 2020. Prior to joining Elementis, John served as chief executive of Spectris plc from January 2006 to September 2018, leading the business through a period of significant strategic transformation and development. Prior to Spectris plc, John spent 14 years at Honeywell International in a number of senior management roles.

Steve Good, Non-Executive Director since 20 October 2014 and Chair of the Remuneration Committee since 25 April 2017, will succeed John as Senior Independent Director, with effect from 1 September 2021.

The Company thanks Andrew for his strong leadership, hard work and commitment over the past seven years. As Chairman, Andrew has overseen the transformation of the Company into a higher quality business and leaves the Company well-positioned for continued success.

Andrew Duff, Chairman, said: "It has been a privilege to chair the Board of Elementis and I wish John, the Board and the Company every success in the future."

On his appointment as Chairman, John O'Higgins said: "On behalf of the Board and everyone at Elementis, I would like to thank Andrew for the enormous contribution he has made during his tenure as Chairman and to wish him the very best for the future. It is a great honour to take on the role of Chair at Elementis. I look forward to working with Paul, the executive team and the Board to continue to execute the Group's strategy and deliver our medium term performance objectives."

The Company confirms that there are no other matters requiring disclosure pursuant to LR 9.6.13R (1) to (6) in respect of the appointments. 

 

Anna Lawrence

General Counsel

0207 067 2999

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWVBRABUBUAR
Date   Source Headline
28th Nov 20255:49 pmRNSTransaction in Own Shares
27th Nov 20255:40 pmRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSElementis acquires personal care specialist
25th Nov 20255:44 pmRNSTransaction in Own Shares
24th Nov 20256:01 pmRNSTransaction in Own Shares
21st Nov 20255:47 pmRNSTransaction in Own Shares
21st Nov 20259:28 amRNSDirector/PDMR Shareholding
20th Nov 20255:34 pmRNSTransaction in Own Shares
19th Nov 20256:08 pmRNSTransaction in Own Shares
18th Nov 20255:45 pmRNSTransaction in Own Shares
17th Nov 20256:03 pmRNSTransaction in Own Shares
14th Nov 20255:31 pmRNSTransaction in Own Shares
13th Nov 20255:39 pmRNSTransaction in Own Shares
12th Nov 20255:29 pmRNSTransaction in Own Shares
11th Nov 20256:02 pmRNSTransaction in Own Shares
10th Nov 20255:56 pmRNSTransaction in Own Shares
7th Nov 20255:33 pmRNSTransaction in Own Shares
6th Nov 20255:34 pmRNSTransaction in Own Shares
5th Nov 20256:13 pmRNSTransaction in Own Shares
4th Nov 20255:40 pmRNSTransaction in Own Shares
3rd Nov 20255:56 pmRNSTransaction in Own Shares
31st Oct 20255:55 pmRNSTransaction in Own Shares
30th Oct 20255:36 pmRNSTransaction in Own Shares
29th Oct 20255:43 pmRNSTransaction in Own Shares
29th Oct 20257:00 amRNSThird Quarter Trading Update
28th Oct 20256:29 pmRNSTransaction in Own Shares
27th Oct 20255:28 pmRNSTransaction in Own Shares
24th Oct 20256:06 pmRNSTransaction in Own Shares
23rd Oct 20255:45 pmRNSTransaction in Own Shares
22nd Oct 20255:35 pmRNSTransaction in Own Shares
21st Oct 20255:48 pmRNSTransaction in Own Shares
20th Oct 20256:10 pmRNSTransaction in Own Shares
17th Oct 20255:31 pmRNSTransaction in Own Shares
16th Oct 20256:00 pmRNSTransaction in Own Shares
15th Oct 20256:27 pmRNSTransaction in Own Shares
15th Oct 20256:25 pmRNSCorrection - Transaction in Own Shares
14th Oct 20255:31 pmRNSTransaction in Own Shares
13th Oct 20255:29 pmRNSTransaction in Own Shares
10th Oct 20255:33 pmRNSTransaction in Own Shares
9th Oct 20255:41 pmRNSTransaction in Own Shares
8th Oct 20255:24 pmRNSTransaction in Own Shares
7th Oct 20255:26 pmRNSTransaction in Own Shares
6th Oct 20255:38 pmRNSTransaction in Own Shares
3rd Oct 20255:35 pmRNSTransaction in Own Shares
2nd Oct 20255:33 pmRNSTransaction in Own Shares
1st Oct 20255:42 pmRNSTransaction in Own Shares
30th Sep 20255:39 pmRNSTransaction in Own Shares
30th Sep 20257:00 amRNSDirectorate Change
29th Sep 20255:13 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.